Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer.

Oncotarget·2026
Same author

Microenvironmentally derived fatty acid-binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma.

Blood neoplasia·2026
Same author

Impaired mitochondrial stress signaling mediates bone loss in male mice in the absence of BNIP3.

bioRxiv : the preprint server for biology·2026
Same author

Expansion of bone marrow adipocytes in obese mice leads to PD-L1-driven bone marrow immunosuppression and osteoclastogenesis.

Bone research·2026
Same author

Cardiovascular signaling proteins as predictors of the cardiac effects of doxorubicin treatment in children with acute lymphoblastic leukemia.

Cardio-oncology (London, England)·2026
Same author

Effect of prophylactic antibiotics on days of antibiotic spectrum coverage in comatose post-cardiac arrest patients: a secondary analysis of PROTECT.

JAC-antimicrobial resistance·2026

相关实验视频

Updated: May 12, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.6K

在小鼠心肌梗塞后,人类心肌源的高增殖细胞改善心脏重塑

Michayla Moore1, Elena Chepurko2, Vadim Chepurko2

  • 1Center for Molecular Medicine, MaineHealth Institute for Research, MaineHealth, Scarborough, Maine; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, Maine.

The Journal of pharmacology and experimental therapeutics
|August 31, 2025
PubMed
概括
此摘要是机器生成的。

来自心脏的人类高增殖细胞 (hHiPC) 显示出心肌修复的潜力. 这些细胞分泌出促血管生成因子,并在受伤后改善心脏功能, 建议用于缺血性心脏病的新细胞疗法.

关键词:
心脏缺血症细胞移植人类高增殖细胞炎症发生

更多相关视频

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.4K
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

1.7K

相关实验视频

Last Updated: May 12, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.6K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.4K
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

1.7K

科学领域:

  • 心血管生物学
  • 复原医学
  • 细胞治疗

背景情况:

  • 来自成人心脏的人类高增殖细胞 (hHiPC) 具有原生和血管性质.
  • 在体内通过hHiPC进行心肌修复的机制在很大程度上尚未研究.
  • 现有的临床试验正在测试与hHiPC共享分子标记的心球衍生细胞.

研究的目的:

  • 描述hHiPCs的蛋白质和分泌物.
  • 在心肌梗塞 (MI) 的小鼠模型中研究hHiPCs的治疗潜力.
  • 要确定hHiPC注射是否改善心脏功能,并防止心脏病发作后的不良转型.

主要方法:

  • 对hHiPCs进行蛋白质和分泌原子分析.
  • 在免疫功能低下的小鼠体内移植hHiPC.
  • 评估细胞存活率,心脏功能 (部分缩短) 和心室重塑.

主要成果:

  • hHiPCs表达和分泌有血管性/有修复性蛋白质 (CXCL6,CTHRC1,CD73).
  • 在心脏病发作后的急性阶段,内心注射hHiPC导致宿主心肌细胞存活.
  • 在MI后的21天和28天,HiPC治疗改善了分数缩短并防止了心室重塑.

结论:

  • hHiPCs具有有利于心脏修复的特性.
  • 在缺血性心肌中生存并发挥有益作用.
  • 在心肌缺血损伤中,HiPCs 是一个有前途的基于细胞的治疗策略.